Who Just RaisedQ-Immune, Inc.
Seattle, WA ยท Biotechnology
Q-Immune, Inc. is a biotechnology company based in Seattle, Washington. In a Form D filed with the SEC on September 28, 2026, it reported raising $25,000 from 1 investor as part of an offering of up to $1,000,000. The first sale in the offering took place on September 24, 2026.
CAR-T can cure. Q-Immune makes it safe, with a lab that teaches AI how engineered cells behave.
- Website
- qimmune.com
- Amount raised
- $25,000
- Offering size
- $1,000,000
- Investors so far
- 1
- First sale
- September 24, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Seattle, Washington
- Incorporated
- Washington, 2025
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $25,000 | $1,000,000 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Washington
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Seattle Neurosound Solutions, Inc. | Seattle, WA | Health Care | $100K | $5M | |
| Hexamer Therapeutics, Inc | Pullman, WA | Health Care | $500K | $2.5M | |
| DexCare, Inc. | Seattle, WA | Health Care | $12.9M | $22.7M | |
| Aptevo Therapeutics Inc. | Seattle, WA | Health Care | $3.5M | $3.5M | |
| MalarVx, Inc. | Seattle, WA | Health Care | $125K | $2.5M | |
| Strella Biotechnology, Inc. | Seattle, WA | Health Care | $1.8M | $3.3M |